Powered by 
Technavio
SYROS PHARMACEUTICALS | Data-Driven Analysis and Industry Review
Published: August 20, 2024Syros Pharmaceuticals is a biotechnology company focused on discovering and developing medicines to address genetic diseases. The company's approach is to understand the genetic basis of diseases and then apply its technology, which includes the Syros Matrisome Medicines Platform, to identify and develop small molecule drugs that control the expression of disease-causing genes. Syros is working on several programs in genetic diseases, including Congenital Adrenal Hyperplasia (CAH) and other rare endocrine disorders. The company's goal is to bring novel medicines to patients with limited or no treatment options. Syros Pharmaceuticals is headquartered in Cambridge, Massachusetts, and has a strong team of scientific and industry experts.'
1. Focus on developing and commercializing specialty pharmaceuticals: Syros Pharmaceuticals is a biotechnology company specializing in the discovery and development of medicines for genetic diseases, with a particular focus on rare monogenic diseases.
2. Utilizes gene control technology: The company's unique approach to gene control leverages the CRISPR-Cas9 system to develop medicines that can correct the root cause of genetic diseases.
3. Collaborations and partnerships: Syros Pharmaceuticals has several collaborations and partnerships, including with the National Institutes of Health (NIH), the Cystic Fibrosis Foundation Therapeutics, and the European Medicines Agency (EMA), to advance its research and development programs.
4. Clinical-stage pipeline: Syros Pharmaceuticals has a clinical-stage pipeline of gene control medicines, including SGX301 for the treatment of rare monogenic diseases caused by the disruption of splicing regulation.
5. Strong intellectual property position: The company holds a significant intellectual property position in the field of gene control, with over 50 issued and pending patents covering its proprietary technology and applications.
1. Syros Pharmaceuticals leverages proprietary gene control technology to discover and develop medicines that address the root causes of genetic diseases.
2. Their business intelligence strategy focuses on utilizing data analytics and advanced modeling techniques to identify potential drug targets and optimize clinical trial design.
3. They employ a data-driven approach to research and development, integrating genomic, epigenomic, and clinical data to accelerate the drug discovery process.
4. Syros Pharmaceuticals collaborates with academic institutions, industry partners, and regulatory agencies to share knowledge and advance the development of innovative treatments.
5. Their business intelligence capabilities enable them to make informed decisions on resource allocation, prioritizing projects based on scientific merit, market potential, and competitive landscape.
Browse Our Research Portfolio In SYROS PHARMACEUTICALS Markets
Health Care
Pharmaceuticals
Pharmaceuticals
About Technavio
With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.
